Why is Every Newborn Forced to Get the Dangerous Hepatitis B Vaccine?

Written by A Midwestern Doctor on September 19, 2025. Posted in Current News

The hepatitis B vaccine has been marred by controversy since its inception, particularly since it is now given to every newborn child despite minimal benefit being attributable to this policy.

•Remarkably, much of that controversy (e.g., Congressional hearings, mainstream news programs, and HIV vaccine contamination concerns) has been largely forgotten.

•The hepatitis B vaccine has long been associated with autoimmune disorders, particularly demyelinating ones. While the medical community has insisted for over 50 years that this link remains unproven and requires “further research”, evidence demonstrates this process indeed occurs.

•While the hepatitis B vaccine has reduced acute cases in high-risk demographics (e.g., intravenous drug users), there is no evidence it has done the same in newborns (as applicable circumstances are incredibly rare), and no evidence it has reduced chronic hepatitis cases (which is the justification for the entire program).

•As such, the official reason every newborn child gets an infant hepatitis B vaccine is not the actual reason why parents and doctors around the country were pressured to administer it to every newborn.

•Tomorrow, the blanket policy to give it to every newborn will at last be re-evaluated. To support this pivotal moment, this article will attempt to establish the actual risks and benefits of the hepatitis B vaccine, along with exposing the forgotten history behind the vaccine, which brought us to where we are now.

In order to have a healthy and meaningful life, people need to have a unifying purpose behind everything they do. Recognizing the importance of this at a young age (as I saw many lacking one struggle greatly), I decided to devote myself to the pursuit of truth, regardless of where it took me. From this, I quickly realized how difficult this was, as on virtually every issue, there is a massive amount of ambiguity, which inevitably leads you reaching false conclusions produced from your existing biases.

Because of this, whenever I try to figure out why something “bad” is happening, I take numerous possibilities (often over a dozen) into consideration, and frequently never fully commit to any as I don’t feel a definitive case was made for any of them—an approach which lies in stark contrast to those who come across one explanation and immediately commit to espousing it (as it “makes sense”). Rather, I patiently wait and have faith I will eventually uncover the thread that ties all the disparate pieces together (which when finally revealed, is an immense source of joy).
Note: this is why, while I sometimes claim things are true, I am also quite deliberate in prefacing other statements with “I suspect” or “I believe.”

The hepatitis B vaccine for example, is one of the most controversial vaccines on the immunization schedule, as some of the strongest arguments both in favor and against vaccination exist for its current use. I’ve hence spent decades trying to figure out why we give it to every newborn in America, and have heard numerous compelling explanations to account for this, but never found one that appeared to explain everything.

Fortunately, two weeks ago, a reader finally provided the answer to this question—an answer I was obligated to publicize, as tomorrow on Thursday (9-18-2025), the ACIP (the independent advisory committee which decides which vaccines are “recommended” to America), after decades, will at last be seriously re-evaluating the appropriateness of giving it to all newborns.

Individuals on both sides have spoken out aggressively in favor of or in opposition to potentially changing the existing hepatitis B recommendation

Note: at a contentious hearing today, the now dismissed CDC director (Daskalakis’s boss), when repeatedly pressed by Senator Rand Paul to do so, was unable to provide any rationale for why we give every newborn the hepatitis B vaccine, despite widely decrying any attempt to overturn it—again illustrating the shaky ground this policy rests upon.

Hepatitis B Safety Concerns

Since entering the market, the hepatitis B vaccine has been marred with safety concerns, particularly after it was given to every child in America. What follows is a brief summary of some of those concerns:

•As early as 1976, one researcher cautioned that since autoimmunity is involved in the pathogenesis of hepatitis B infections, it they might also be provoked by molecularly similar hepatitis B vaccines. Since that time, many other papers have shown the vaccine provokes a wide range of autoimmune disordes.^1,2,3,4,5

•One researcher, Bohn Dunbar (a respected vaccine researcher who was a medical school professor), after her brother and research assistant both developed autoimmune and neurological injuries from the vaccine in 1994, devoted herself to exposing the frequent pattern of autoimmune complications from the vaccine (e.g., “Dr. Dunbar has also been in contact with numerous physicians and research scientists from several countries who have independently described thousands of identical severe reactions occurring in Caucasian recipients of the vaccine”). In turn, due to both her prestige and ability to navigate the academic publishing system, she brought significant attention to this subject (e.g., see this 1999 Washington Post article).

•A 1998 Article in Scientist highlighted growing concerns threatening to derail the hepatitis B vaccine program, such as more and more people claiming it caused serious autoimmune diseases (e.g., rheumatoid arthritis [RA], optic neuritis, and multiple sclerosis [MS]), that one doctor had collected over 600 cases of this happening, and that in July, attorneys representing 15,000 people sued France’s government for exaggerating the vaccine’s benefits and downplaying its risks.

•Shortly after, France suspended hepatitis B vaccinations in schools (to assess if it could cause demyelinating diseases), which the WHO, the ACIP, and France’s medical associations all strongly condemned due to it weakening public confidence in the vaccine.

•In January 1999 (one of the last times major news networks still aired programs critical of pharmaceutical interests—as Clinton has recently legalized pharmaceutical companies buying them out), ABC news hosted an almost entirely forgotten program on the hepatitis B vaccine, which featured a chief CDC and Merck official (who claimed mass vaccination justified preventing a few hepatitis cases and that no injuries attributed to the vaccine were actually caused by it) along with many vaccine injured patients, including both injured adults and parents of severely injured children.

Shortly after, at a May 1999 Congressional hearing discussing the merits of universal hepatitis B vaccination of newborns, in addition to many espousing the need for it, the following objections were raised in testimonials from experts and vaccine-injured parties who testified against the practice:

• Severe Adverse Reactions: Numerous serious side effects were discussed, including infant death, seizures, autism, dysautonomia, MS, RA diabetes, and rare cases of liver cancer in children post-vaccination (along with established mechanisms for the autoimmune responses). VAERS data in turn, indicated over 8,000 reactions, including 43 deaths in children under 2 in 1997. In contrast, there were only 95 annual hepatitis B cases in this demographic (with comparable, or smaller, numbers seen in other datasets)—suggesting injuries vastly outweighed prevented hepatitis cases (particularly since less than 1% of injuries are typically reported to VAERS and infant deaths from hepatitis were virtually non-existent in the pre-vaccination era).
  Note: at each point in time where the safety of the hepatitis B vaccine was questioned, the same pattern of injuries (e.g., characteristic autoimmune disorders and infant deaths) in VAERS was cited, with the total number of them continually increasing as the years went by.
• Inadequate Safety Monitoring and Research: Adverse reaction reports were often ignored or dismissed, with short trial durations (4–5 days), missing delayed reactions like MS or diabetes, which may appear years later. No studies focused on newborns or genetic predispositions, and underreporting was common due to physician denial.
• Lack of Informed Consent and Coercion: Parents received inadequate risk information, with CDC materials omitting serious adverse effects listed in manufacturer inserts. Newborns were vaccinated without parental consent, and some faced coercion, including threats of social services intervention.
• Questionable Mandate: Vaccinating low-risk newborns for an adult-associated disease is inappropriate, particularly since immunity can wane before adolescence and 10–30% of individuals fail to produce antibodies, questioning efficacy.
• Conflicts of Interest: Pharmaceutical influence on health agencies raised doubts about study objectivity.
• Vaccine Injury Compensation Issues: The National Vaccine Injury Compensation Program denied most claims, leaving victims unsupported despite a $1 billion trust fund, with restrictions limiting filings for hepatitis B vaccine injuries.

Note: most of the above has also been said about many other vaccines over the decades. Likewise, in a 1999 testimony before the Ohio legislature, another physician noted that most of the deaths following hepatitis B were classified as SIDS (a condition extensive evidence shows is strongly linked to vaccination) yet SIDS was almost always defined as occurring between 1 month to 1 year of age, and that prior to the hepatitis B vaccine being given to newborns, it rarely if ever affected children under 2 months of age—however in VAERS, many cases labeled as SIDS were reported in infants under one month of age following the vaccination. Furthermore, a relatively unknown 2004 study found the hepatitis B vaccine increased the risk of at 7-12 months of age by 1.81X (although this may in part have been due to vaccine induced immune suppression making African children more vulnerable to existing infections).

One of the Congressional witnesses, in turn, produced an excellent (referenced) summary of the major issues with the hepatitis B vaccine which included two cases he’d observed it causing encephalomyelitis (resulting in a two week coma for one, a four week coma for the other, along with optic neuritis and significant neurological disability for both, and no clear conventional explanation for what had occurred) along with many cases of it causing chronic fatigue syndrome. He then compiled a list of dozens of studies demonstrating that the hepatitis B vaccine was linked to a myriad of autoimmune disorders, as did two other author decades later (e.g., in a 2015 textbook on the subject or within a natural health database). Those studies (which are likely only the tip of the iceberg) are as follows:

• Multiple Sclerosis,^{1,2,3,4,5,6,7,8,9,10,11,12,13,14} myelitis,^{1,2,3,4,5,6,7,8,9,10,11,12,13,14} encephalitis,¹ encephalomyelitis,¹ optic neuritis,^1,2,3,4,5 Guillain–Barré syndrome,^{1,2,3,4,5,6,7,8,9} neuropathy,^{1,2,3,4,5,6,7,8,9,10} myopathy,^{1,2,3,4,5,6,7,8} Myasthenia Gravis,^1,2,3 APMPPE (an eye disease)¹ uveitis¹,
• Arthritis,^{1,2,3,4,5,6,7,8,9,10,11,12,13} Lupus,^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22} juvenile dermatomyositis,^1,2,3,4,5 macrophagic myofasciitis,¹ polyarthralgia-myalgia,¹ Still’s disease¹
• Vasculitis (general,^1,2,3,4 pulmonary and cutaneous,^1,2 Churg-Strauss,^1,2 Henoch–Schonlein purpura,¹ Kawasaki’s disease¹ polyarteritis nodosa¹), hemolytic anemia,¹ thrombocytopenia,^{1,2,3,4,5,6,7} antiphospholipid syndrome^1,2
• Lichen planus,^{1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19} lichen striatus,¹ bullous pemphigoid,^1,2 erythema multiforme,^1,2,3 erythema nodosum¹ Gianotti–Crosti syndrome,^1,2 alopecia,^1,2 buchal aphthosis¹
• Chronic Fatigue Syndrome,^1,2,3,4,5 Fibromyalgia,¹ Graves’ disease,^1,2 Sjogren’s syndrome¹
• Hepatitis,¹,^2,3,4 glomerulonephritis,¹ pancreatitis¹ pneumonitits¹

Note: the hepatitis B vaccine has also been linked to a variety of other disorders not classically classified as autoimmune disorders such as seizures,^1,2 Bell’s palsy,^1,2 cerebellar ataxia,¹ tic disorders,¹ anorexia,¹ tufted angioma¹ and to increase common childhood illnesses (e.g., one study found a 1.6X increase in acute ear infections and a 1.41X increase in pharyngitis and nasopharyngitis).

As mentioned above, since the start, it was widely believed that the autoimmune conditions the hepatitis B vaccine caused were due to its antigen having a significant overlap with human myelin (particularly since many of the autoimmune disorders associated with the vaccine were also observed to sometimes occur from a hepatitis B infection).

The molecular mimicry of the vaccine, in turn, was a hotly debated topic that all medical authorities denied was occurring. As it was not possible to assess with the technology of the time, the absence of evidence for it was treated as evidence that it did not.

Note: a definitive 1994 report by the Institute of Medicine noted that while preliminary data existed for many of the injuries attributed to the hepatitis B vaccine, no further research had ever been done, so there was insufficient evidence to prove or disprove a link between these conditions, and concluded its report on the safety of the childhood vaccines by declaring that the lack of adequate data regarding many of the adverse events under study was of significant concern to the committee (but as you might guess, the studies they requested still have not been done).

However, while it was not possible to assess then, a 2005 study showed the hepatitis B vaccine did, indeed, have a significant overlap with myelin and more importantly, that 60% of its recipients also developed immune reactivity to the myelin coasting their nerves (which in the majority of cases persisted for over 6 months). Sadly, by the time this was discovered, the use of the hepatitis B vaccine had been normalized, and public debate on its safety or autoimmunity risk had long since ended.
Note: a 2001 review also highlighted the potential for this mimicry to cause MS, while another paper highlighted that the vaccine overlaps with Epstein-Barr Virus in a manner which could provoke demyelinating disorders in recipients with existing EBV infections.

Likewise:

•A 2005 VAERS study comparing adults who’d received a tetanus-containing vaccine to a hepatitis B vaccine found they were much more likely to develop a variety of autoimmune disorders (5.2X for MS, 18X for RA, 14X for optic neuritis, 9.1X for lupus, 7.2X for alopecia, 2.6X for vasculitis, and 2.3X for thrombocytopenia). A similar 2002 study found a 6.1X increase for chronic arthritis (persisting for at least one year), which affected women 3.5X as much as men, and on average occurred 16 days after vaccination.

•A 2002 study found individuals who received a hepatitis B vaccine, within the next two months, were 1.8 times as likely to experience a demyelinating event.

•A 2015 study found cases of MS in France rose by 65% in the years following an aggressive national campaign to increase hepatitis B vaccination rates, and that a statistically significant correlation existed between the number of hepatitis B vaccine doses given and the number of MS cases 1-2 years later.

•A 2004 study analyzed primary care records from across England to compare 163 MS patients with 1,604 randomly selected matched controls without MS. It found that MS patients were three times more likely to have received the hepatitis B vaccine within three years of symptom onset, with no similar risk linked to tetanus or influenza vaccines—indicating this was a specific issue with the hepatitis B vaccine.

•A 2009 study in children found that the GSK’s hepatitis B vaccine, which contains five times more yeast protein antigen than other brands, was associated with a 2.77X increased risk of developing MS in vaccine-compliant children. A smaller increase (1.5X) was observed for other CNS inflammatory demyelinating disorders in children who adhered to recommended vaccination schedules.

Additionally, the hepatitis B vaccine has also been repeatedly linked to autism and other developmental disabilities:

• In a June interview with Tucker Carlson, Secretary Kennedy revealed that in 1999, the CDC conducted a study which found that receiving a hepatitis B vaccine in the first 30 days of life caused a 12.35X increase in autism. As this was unacceptable, they conducted numerous attempts to adjust the data to hide the risk, but were unable to make the link go away, gave up, and never published it.

An abstract of a 1999 study (which is likely what RFK was referring to) was subsequently made available to a Florida Congressmen who had worked with vaccine whistleblowers, which showed (via the CDC’s private VSD database) that when infants received the highest doses of mercury containing vaccines (compared to those who had not been vaccinated), there was a 1.8X increase in neurologic development disorders, a 7.6X increase in autism, a 5.0X increase in nonorganic sleep disorders and a 2.1X increase in nonorganic sleep disorders.

•A 2007 study of 1824 children found boys who received the hepatitis B vaccine (prior to 2000 when it still used thimerosal) were 9 times as likely to have a developmental disability.

•A follow-up 2010 study found neonatal hepatitis B vaccination (compared to no hepatitis B vaccination or simply getting it later in life) made children 3 times as likely to develop autism. Finally, a 2017 study found mercury containing hepatitis B vaccines at the start of life increased the risk of autism by 4.6-6.7X (along with a 2015 study which found they increased the risk of developmental delays by 1.6X-1.7X along with a 2016 followup which estimated this equated to over a trillion in healthcare costs).

Similar results were also seen in animals:

•A 2010 monkey study determined that the vaccine caused a significant delay in the acquisition of root, snout, and suck reflexes (critical processes for development).

•A 2016 mouse study found the vaccine impaired neurogenesis, behavioral performances and hippocampal long-term potentiation which simultaneously increasing brain inflammation (which was proportional to the neurologic damage which occurred). A follow-up 2018 study determined many of these effects (particularly in the hippocampus) were a result of elevated IL-4.

Find the rest at www.midwesterndoctor.com

Please Donate Below To Support Our Ongoing Work To Expose The Lies About Covid 19

PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX. 

Trackback from your site.